| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 08/16/1995 | EP0666906A1 Cho cells expressing human endothelin receptors |
| 08/16/1995 | EP0666856A1 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
| 08/16/1995 | EP0666849A1 Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis |
| 08/16/1995 | EP0666758A1 Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
| 08/16/1995 | EP0666757A1 Anti-inflammatory, tolerogenic and immunostimulatory properties of carbohydrate binding-proteins |
| 08/16/1995 | EP0666754A1 Synthetic lung surfactant having antioxidant properties |
| 08/16/1995 | EP0666736A1 Stabilization of fluorocarbon emulsions. |
| 08/16/1995 | CN1106812A Tricyclic diazepine vasopressin antagonists |
| 08/16/1995 | CN1106802A Tricyclic benzazepine vasopressin antagonists |
| 08/16/1995 | CN1106801A Isoquinolines |
| 08/15/1995 | US5441977 Immunosuppressive agent; for treating transplant rejection |
| 08/15/1995 | US5441976 Immunostimulants |
| 08/15/1995 | US5441960 1-pyrimidinylacetamide human leukocyte elastate inhibitors |
| 08/10/1995 | WO1995021187A1 Cyclic neurokinin a antagonists |
| 08/09/1995 | EP0665844A1 Substituted benzylaminoquinuclidines as substance p antagonists |
| 08/09/1995 | EP0665843A1 Substituted quinuclidines as substance p antagonists |
| 08/09/1995 | EP0665842A1 Sulfonamide derivatives of benzenefused hydroxy substituted cycloalkyl and heterocyclic ring compounds |
| 08/09/1995 | EP0665744A1 Stable extended release oral dosage composition |
| 08/09/1995 | EP0601123B1 Low speed model following velocity command system for rotary wing aircraft |
| 08/08/1995 | US5440036 1,4-benzoxazine derivatives |
| 08/08/1995 | US5440035 Leukotriene antagonists; antiallergens, antiinflammatory agents |
| 08/08/1995 | US5439929 Bicyclic carbamates, pharmaceutical compositions and use |
| 08/08/1995 | US5439927 For potassium channel opening, hypotensive agents, broncho- or vasodilators, gastrointestinal disorders |
| 08/08/1995 | US5439925 Di(aromatic) compounds and their use in human and veterinary medicine and in cosmetics |
| 08/08/1995 | US5439895 4-aminoquinazoline derivatives |
| 08/03/1995 | WO1995020581A1 Novel human leukocyte elastase (hle) inhibitors, and related pharmaceutical compositions and methods of use |
| 08/03/1995 | WO1995020578A1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS |
| 08/03/1995 | WO1995020575A1 Aralkylamino substituted azacyclic therapeutic agents |
| 08/03/1995 | WO1995020393A1 Use of mometasone furoate for treating airway passage and lung diseases |
| 08/03/1995 | WO1995020386A1 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists |
| 08/03/1995 | CA2182203A1 Novel human leukocyte elastase (hle) inhibitors, and related pharmaceutical compositions and methods of use |
| 08/03/1995 | CA2181376A1 Aralkylamino substituted azacyclic therapeutic agents |
| 08/02/1995 | EP0665227A1 Polyhydronorharman synthase inhibitors |
| 08/02/1995 | EP0664788A1 Substituted ethanolamine esters |
| 08/02/1995 | EP0664711A1 Peptide inhibitors of cellular adhesion |
| 08/02/1995 | CN1106007A Novel sulfonylamino pyrimidines |
| 08/01/1995 | US5438141 Heteroaryl and haloaryl quinoline derivatives of cyclopropaneacetic acid as leukotriene antagonists |
| 08/01/1995 | US5437272 Supplying respiratory gas under positive pressure; maintaining respiratory gas exchange in perfluorocarbon liquid-filled pulmonary air passages |
| 08/01/1995 | CA2141231A1 6-azaindole thromboxane synthase inhibitors |
| 08/01/1995 | CA2140953A1 Polyhydronorharman synthase inhibitors |
| 08/01/1995 | CA1336516C Acyl derivatives of 2-amino-4-substituted-5-hydroxy pyrimidines |
| 08/01/1995 | CA1336503C Use of 5-heteroaryl- or 5-aryl-substituted imidazo[2,1-a] isoquinolines |
| 07/27/1995 | WO1995019978A1 Tetracyclic derivatives, process of preparation and use |
| 07/27/1995 | WO1995019959A1 Amino acid derivatives and their use as phospholipase a2 inhibitors |
| 07/27/1995 | WO1995019952A1 Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure |
| 07/27/1995 | CA2181581A1 Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure |
| 07/26/1995 | EP0664289A2 Isoquinolines |
| 07/26/1995 | EP0664287A1 Vitamin D Compounds and method of preparing these compounds |
| 07/26/1995 | EP0664127A2 Pharmaceutical compositions containing isoquinoline derivatives |
| 07/26/1995 | EP0663916A1 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 07/26/1995 | EP0663903A1 1,2-dihydro-2-oxo-3-amino quinoxaline derivatives, preparation thereof and application in therapy. |
| 07/26/1995 | EP0663902A1 25-carboxylic acid derivatives in the vitamin d series, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicines |
| 07/26/1995 | EP0663830A1 Method of treating lung disease with uridine triphosphates |
| 07/26/1995 | EP0663828A1 Compositions for treating allergic disorders using (-) cetirizine |
| 07/26/1995 | EP0663824A1 Potassium channel activating compounds and methods of use thereof |
| 07/26/1995 | EP0663822A1 Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine |
| 07/26/1995 | CN1105576A Oil agent for curing rhinitis |
| 07/25/1995 | US5436233 Nervous system disorders |
| 07/25/1995 | CA2140722A1 Beta-carboline thromboxane synthase inhibitors |
| 07/20/1995 | WO1995019436A1 Mammalian monocyte chemoattractant protein receptors |
| 07/20/1995 | WO1995019431A1 Zinc finger protein derivatives and methods therefor |
| 07/20/1995 | WO1995019362A1 Dihydro pyrazolopyrroles |
| 07/20/1995 | WO1995019344A1 Gem-disubstituted azacyclic tachykinin antagonists |
| 07/20/1995 | CA2180746A1 Gem-disubstituted azacyclic tachykinin antagonists |
| 07/19/1995 | EP0663406A1 VIP analog |
| 07/19/1995 | EP0662957A1 1,4-disubstituted piperazines useful in the therapy of the asthma and of the inflammation of the respiratory tract |
| 07/19/1995 | EP0662950A1 Benzenealkanoic acids for cardiovascular diseases |
| 07/18/1995 | US5434248 Peptidyl derivatives as inhibitors of interleukin-1β converting enzyme |
| 07/18/1995 | US5434158 Asthma |
| 07/18/1995 | US5434149 Phosphodiesterase inhibitors |
| 07/13/1995 | WO1995018793A1 Novel heterocyclic compounds |
| 07/13/1995 | WO1995018615A1 A method of treating neurogenic inflammation |
| 07/13/1995 | WO1995018610A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 07/13/1995 | CA2180239A1 A method of treating neurogenic inflammation |
| 07/13/1995 | CA2180238A1 Novel heterocyclic compounds |
| 07/13/1995 | CA2180123A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 07/12/1995 | EP0662087A1 Retinal pigmented epithelium derived neurotrophic factor |
| 07/12/1995 | EP0661992A1 Pharmaceutical formulations of interleukin-1 inhibitors |
| 07/12/1995 | EP0661975A1 Methods and compositions for treating allergic disorders using optically pure (+) cetirizine |
| 07/12/1995 | EP0661971A1 Methods and compositions for treating hypertension, angina, and other disorders using optically pure s(-) felodipine |
| 07/12/1995 | EP0661970A1 Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine |
| 07/11/1995 | US5432189 Bis-aryl amide and urea antagonists of platelet activating factor |
| 07/11/1995 | US5432181 Substituted heteroaryl analogs of 4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
| 07/06/1995 | WO1995018132A1 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists |
| 07/06/1995 | WO1995018131A1 New ginkgolide derivatives and a process for preparing them |
| 07/06/1995 | WO1995018128A1 Pyrazolopyridine adenosine antagonists |
| 07/06/1995 | WO1995018107A1 Process for the preparation of leukotriene antagonists |
| 07/06/1995 | WO1995017904A2 Botulinum toxins for treating various disorders and associated pain |
| 07/06/1995 | CA2682117A1 The use of the neurotoxic component of a botulinum toxin for the treatment of a facial disease, disorder or condition |
| 07/06/1995 | CA2180253A1 Pyrazolopyridine adenosine antagonists |
| 07/06/1995 | CA2180014A1 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists |
| 07/06/1995 | CA2177736A1 New ginkgolide derivatives and a process for preparing them |
| 07/05/1995 | EP0661269A1 Substituted heterocyclic carboxylic acid amides, their preparation and their use as medicaments |
| 07/05/1995 | EP0660716A1 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| 07/04/1995 | US5430032 Treating asthma, allergy, inflammation |
| 07/04/1995 | US5430025 Elastase-inhibiting peptides bearing a C-terminal trifluoromethylketone moiety |
| 07/01/1995 | CA2138929A1 Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals |
| 06/29/1995 | WO1995017399A1 Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitors |
| 06/29/1995 | WO1995017392A1 Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitor |
| 06/29/1995 | WO1995017379A1 Phenylthiophenyl cycloalkenyl hydroxyureas as lipoxygenase inhibitors |